Lataa...
The evolving role of zoledronic acid in early breast cancer
Most women with early breast cancer (BC) have an excellent prognosis and will remain disease-free for many years after treatment. However, bone-specific side effects of cancer therapies can have a negative effect on patients’ long-term bone health. The accelerated bone loss associated with BC therap...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2886321/ https://ncbi.nlm.nih.gov/pubmed/20616898 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|